Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuechan Ruanjian Rougan Tablet
- Development stage
- Unknown
- Lead developer
- Shanghai Tianchan Biotechnology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xuechan Ruanjian Rougan Tablet is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Tianchan Biotechnology for the treatment of liver fibrosis associated with chronic hepatitis B. The drug is designed based on the TCM therapeutic principles of 'softening hardness and nourishing the liver' (Ruanjian Rougan), which aims to reverse or halt the progression of hepatic fibrosis by modulating the liver microenvironment. It is currently being evaluated in Phase II clinical trials in China (e.g., CTR20231809), where its efficacy is primarily measured by the proportion of patients achieving a reduction in the Ishak fibrosis score by at least one stage.
- Brand names
- Xuechan Ruanjian Rougan Tablet
- Other names
- 雪蟾软坚柔肝片
Beyond the preview
Go deeper on Xuechan Ruanjian Rougan Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuechan Ruanjian Rougan Tablet.